
宜联生物
宜联生物
Biotech/Healthcare
Founded in 2020, Elpiscience Biopharma was established by a team with experience in end-to-end development of innovative antibody-drug conjugates (ADCs) and extensive corporate management expertise in China and overseas. The company develops globally competitive conjugated therapeutics and is…
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.